Novel strategies to improve blood pressure control and treat drug-resistant hypertension are needed despite the efficacy and widespread availability of current antihypertensive drugs. In this Review, Mahfoud and colleagues summarize the pathophysiological rationale and available clinical evidence for device-based therapies for hypertension, including renal sympathetic denervation.
- Lucas Lauder
- Michel Azizi
- Felix Mahfoud
